Hutch News
Remembering transplant immunologist Dr. John Hansen
Physician-scientist defined rules for matching bone marrow transplant donors and patients, was a founding father of volunteer donor registries
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Targeting a subset of stem cells shows lasting, therapeutically relevant gene editing in blood cells
A new Science Translational Medicine paper is first to report how editing a portion of stem cells with CRISPR/Cas9 is sufficient for long-term reactivation of therapeutic hemoglobin
From Omaha to a Seattle lab, with 2 side trips to hell
Childhood AML survivor interns with the scientist who sequenced her genome
Cancer cells reconnect with their inner child to evade immunotherapy
Turning on an embryonic gene may help some tumors resist immune checkpoint inhibitors
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Interferon gamma brings the heat to cold tumors
From the Pollack Lab, Clinical Research Division
Improving CRISPR with a heart of gold
From the Adair Lab, Clinical Research Division
Improving HIV clinical trials with mobile technology
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Immunotherapy trailblazer Dr. Phil Greenberg to receive E. Donnall Thomas Lecture and Prize
American Society of Hematology honors his ‘vision, creativity and scientific rigor’ in T-cell therapy research
Fred Hutch global health research honored for impact, collaboration
Washington Global Health Alliance awardees include Dr. Benjamin O. Anderson and a collaboration between Dr. Jerald Radich and The Max Foundation
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
Turning down the heat
From the Deeg Laboratory, Clinical Research Division
TCR-engineered T cell therapy enhanced by modulating macrophages
From the Hingorani and Greenberg Laboratories, Clinical Research Division
Natural language processing as a research aid
From the Divisions of Clinical Research and Public Health Sciences
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Continuing a legacy
Ahmed Diab, an inaugural winner of the Dr. Eddie Méndez Award, remembers his mentor
Dr. Nancy E. Davidson receives Raisbeck Endowed Chair for Collaborative Research
New chair will encourage collaboration between Fred Hutch and the University of Washington
Landmark scientific paper turns 40
First unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy, modern bone marrow transplantation
The great antiepileptic debate
From the Martin Laboratory, Clinical Research Division
Logic-gated CAR-T cells safely target distant tumor cells
From the Riddell Laboratory, Clinical Research Division
The latest in prostate cancer research: 7 takeaways
7 takeaways from community symposium highlighting recent advances in prevention, screening and treatment
Leukemia research leader Dr. Fred Appelbaum named ‘Giant of Cancer Care’
Physician-scientist and Hutch VP honored for contributions to research, patient care
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma